Anti-CD79a antibody [EPR3619]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Knockout Tested Rabbit Recombinant Monoclonal CD79A antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 3 publications.
View Alternative Names
CD79a, IGA, MB1, CD79A, B-cell antigen receptor complex-associated protein alpha chain, Ig-alpha, MB-1 membrane glycoprotein, Membrane-bound immunoglobulin-associated protein, Surface IgM-associated protein
- Flow Cyt
Unknown
Flow Cytometry - Anti-CD79a antibody [EPR3619] (AB133483)
Flow cytometric analysis of permeabilised Ramos cells labelled with ab133483 at 1/100 dilution (red) or negative rabbit IgG (green).
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-CD79a antibody [EPR3619] (AB133483)
Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) with ab133483 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (left). Cells were fixed and permeabilised with BD Cytofix/Cytoperm™ for 20 min. PBMCs were incubated for 30 mins on ice in 1x PBS containing 10 µg/ml human IgG and 10 % normal goat serum to block FC receptors and non-specific protein-protein interaction followed by the antibody ab133483 or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (1x 106 in 100 µl at 0.008 μg/ml (1/62,5000 dilution) for 30 mins at 22°C . The cells were simultaneously stained with CD19.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 dilution for 30 mins at 22°C
Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on CD19+.
- WB
Unknown
Western blot - Anti-CD79a antibody [EPR3619] (AB133483)
All lanes:
Western blot - Anti-CD79a antibody [EPR3619] (ab133483) at 1/1000 dilution
Lane 1:
Raji cell lysate at 10 µg
Lane 2:
Ramos cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 25 kDa
false
- WB
Lab
Western blot - Anti-CD79a antibody [EPR3619] (AB133483)
False colour image of Western blot : Anti-CD79a antibody [EPR3619] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab133483 was shown to bind specifically to CD79a. A band was observed at 50 kDa in wild-type Raji cell lysates with no signal observed at this size in CD79A knockout cell line ab274911 (knockout cell lysate ab281361). To generate this image, wild-type and CD79A knockout Raji cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-CD79a antibody [EPR3619] (ab133483) at 1/1000 dilution
Lane 1:
Wild-type Raji cell lysate at 20 µg
Lane 2:
CD79A knockout Raji cell lysate at 20 µg
Lane 3:
Daudi cell lysate at 20 µg
Secondary
Lanes 1 - 3:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 3:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 50 kDa
false
Related conjugates and formulations (2)
-
Anti-CD79a antibody [EPR3619] - BSA and Azide free
-
578 PE
PE Anti-CD79a antibody [EPR3619]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein acts as an essential mediator in the immune system. CD79a together with CD79b forms part of the BCR complex critical for B cell development and maturation. The BCR complex activates signaling cascades that influence B cell fate decisions such as proliferation differentiation and apoptosis. By transmitting signals from the BCR CD79a helps regulate these cellular functions necessary for efficient immune defense.
Pathways
CD79a plays a pivotal role in the B cell receptor signaling pathway. This pathway involves signaling molecules such as spleen tyrosine kinase (SYK) and phosphoinositide 3-kinase (PI3K) which are activated upon BCR engagement. CD79a acts in concert with other proteins including CD79b and the IgM receptor facilitating downstream signaling cascades that ensure proper B cell responses. Its role is important for linking extracellular antigen recognition to intracellular signaling events.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 30:456 PubMed40762017
2025
Applications
Unspecified application
Species
Unspecified reactive species
Genome biology 26:124 PubMed40346709
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 28:468 PubMed39119236
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com